tiprankstipranks
Santen Pharmaceutical Co Ltd (SNPHY)
OTHER OTC:SNPHY
US Market
SNPHY
Santen Pharmaceutical Co
RESEARCH TOOLSreports
Want to see SNPHY full AI Analyst Report?

Santen Pharmaceutical Co (SNPHY) Cash flow

5 Followers

Santen Pharmaceutical Co Cash Flow

SNPHY's free cash flow for Q4 2025 was ¥17.96B. For the 2025 fiscal year, SNPHY's free cash flow was decreased by ¥15.40B and operating cash flow was ¥18.89B. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 26Mar 25Mar 24Mar 23
Operating Cash Flow
¥ 60.93B¥ 46.12B¥ 72.65B¥ 37.15B¥ 46.04B
Investing Cash Flow
¥ -8.22B¥ -13.76B¥ -6.14B¥ -26.78B¥ -35.17B
Financing Cash Flow
¥ -53.31B¥ -52.32B¥ -34.03B¥ -37.22B¥ 5.56B
End Cash Position
¥ 93.00B¥ 81.23B¥ 94.58B¥ 57.90B¥ 83.01B
Free Cash Flow
¥ 54.27B¥ 38.87B¥ 61.96B¥ 12.56B¥ 10.20B
Currency in JPY

Santen Pharmaceutical Co Cash Flow